Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02557893
Other study ID # R01NR008131
Secondary ID
Status Completed
Phase N/A
First received September 9, 2015
Last updated September 22, 2015
Start date April 2006
Est. completion date October 2007

Study information

Verified date September 2015
Source University of Georgia
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Pregnant women at increased risk for back pain were studied during the second trimester and randomized to12-weeks of resistance exercise, education or waitlist. Several outcomes were assessed including physical function, quality of life and mood.


Description:

A parallel group trial was completed at a single site. Second trimester women (n=134) were randomly assigned (in blocks of 3) to 12-weeks of wait list, bi-monthly pregnancy education classes or twice weekly low-to-moderate intensity resistance training. Resistance training involved one abdominal exercise with no external load and five exercises with an external load that gradually progressed (leg extension, leg press, arm lat pull, leg curl, and lumbar extension). Several outcomes were assessed including physical function, quality of life and mood.


Recruitment information / eligibility

Status Completed
Enrollment 134
Est. completion date October 2007
Est. primary completion date October 2007
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 38 Years
Eligibility Inclusion Criteria:

- Pregnant and able to complete baseline testing during gestational week 21 to 25 of pregnancy.

Exclusion Criteria:

- Regular resistance exercise training (= twice per week during the past month)

- an orthopedic or cardiovascular limitation

- a psychiatric disorder

- or had in the current or a prior pregnancy any of the following:

- two or more miscarriages

- premature labor

- placental previa,

- poor fetal growth,

- low pre-pregnancy body weight (BMI < 17.5)

- a multiple birth pregnancy

- pre-eclampsia

- preterm rupture of membranes

- uterine growth retardation

- incompetent cervix/cerclage

- recurrent vaginal bleeding

- anemia or

- diabetes.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Resistance exercise
Resistance exercise involved 12-weeks of strength training twice per week
Other:
Education
Bimonthly pregnancy education classes
Wait list
Wait list participants were tested on the outcomes during their pregnancy and were eligible to participate in a post-partum supervised exercise program. The wait list participants formed a no treatment control group.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Georgia

References & Publications (1)

O'Connor PJ, Poudevigne MS, Cress ME, Motl RW, Clapp JF 3rd. Safety and efficacy of supervised strength training adopted in pregnancy. J Phys Act Health. 2011 Mar;8(3):309-20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Physical function measured with physical tests such as time to make a bed, get up and down off the floor and pick up scarves from the floor. The intervention occurred from weeks 22 to 34 of pregnancy and the outcomes were measured the week before and after the intervention. Change from week 21 to 35 of pregnancy No
Primary Quality of life measured using the Short Form 36 Healthy Survey. The intervention occurred from weeks 22 to 34 of pregnancy and the outcomes were measured the week before and after the intervention. Change from week 21 to 35 of pregnancy No
Primary Mood measured using the Profile of Mood States questionnaire. The intervention occurred from weeks 22 to 34 of pregnancy and the outcomes were measured the week before and after the intervention. Change from week 21 to 35 of pregnancy No
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Completed NCT02408315 - Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE) Phase 3